BioNTech criticises EU failure to order enough Covid vaccineJanuary 1, 2021
Firm races to fill potential gap left by bloc’s gamble on several vaccines being approved
- Coronavirus – latest updates
- See all our coronavirus coverage
BioNtech has criticised the EU’s failure to order more doses of its coronavirus vaccine, saying it is now racing with its US partner, Pfizer, to boost production amid fears of a European “gap” left by the lack of other approved vaccines.
The Pfizer/BioNTech vaccine was the first to be approved by the bloc late last month, after being accepted by the UK, Canada and the US. They and other countries have also since approved the Moderna or Oxford/AstraZeneca vaccine, leaving the EU trailing behind.